vs

Side-by-side financial comparison of OMNICELL, INC. (OMCL) and Zepp Health Corp (ZEPP). Click either name above to swap in a different company.

OMNICELL, INC. is the larger business by last-quarter revenue ($314.0M vs $10.5M, roughly 30.0× Zepp Health Corp). Over the past eight quarters, OMNICELL, INC.'s revenue compounded faster (12.9% CAGR vs -7.9%).

Omnicell, Inc. is an American multinational healthcare technology company headquartered in Mountain View, CA. It manufactures automated systems for medication management in hospitals and other healthcare settings, and medication adherence packaging and patient engagement software used by retail pharmacies. Its products are sold under the brand names Omnicell and EnlivenHealth.

Zepp Health Corp is a global digital health and smart wearable technology company. It develops and sells fitness trackers, smartwatches, and AI-powered health monitoring tools, serving individual consumers, sports teams, and healthcare providers across Asia, North America, and Europe, with core focus on wellness tracking and remote health management solutions.

OMCL vs ZEPP — Head-to-Head

Bigger by revenue
OMCL
OMCL
30.0× larger
OMCL
$314.0M
$10.5M
ZEPP
Faster 2-yr revenue CAGR
OMCL
OMCL
Annualised
OMCL
12.9%
-7.9%
ZEPP

Income Statement — Q4 2025 vs Q3 2025

Metric
OMCL
OMCL
ZEPP
ZEPP
Revenue
$314.0M
$10.5M
Net Profit
$-223.0K
Gross Margin
41.5%
38.2%
Operating Margin
0.1%
-1.2%
Net Margin
-2.1%
Revenue YoY
2.3%
Net Profit YoY
EPS (diluted)
$-0.05
$-0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OMCL
OMCL
ZEPP
ZEPP
Q4 25
$314.0M
Q3 25
$310.6M
$10.5M
Q2 25
$290.6M
$8.2M
Q1 25
$269.7M
$5.3M
Q4 24
$306.9M
Q3 24
$282.4M
$5.9M
Q2 24
$276.8M
$5.6M
Q1 24
$246.2M
$5.5M
Net Profit
OMCL
OMCL
ZEPP
ZEPP
Q4 25
Q3 25
$5.5M
$-223.0K
Q2 25
$5.6M
$-1.1M
Q1 25
$-7.0M
$-2.7M
Q4 24
Q3 24
$8.6M
$-1.8M
Q2 24
$3.7M
$-1.5M
Q1 24
$-15.7M
$-2.0M
Gross Margin
OMCL
OMCL
ZEPP
ZEPP
Q4 25
41.5%
Q3 25
43.3%
38.2%
Q2 25
43.9%
36.2%
Q1 25
41.1%
37.3%
Q4 24
46.2%
Q3 24
43.3%
40.6%
Q2 24
41.3%
40.3%
Q1 24
37.6%
36.8%
Operating Margin
OMCL
OMCL
ZEPP
ZEPP
Q4 25
0.1%
Q3 25
2.7%
-1.2%
Q2 25
2.8%
-10.3%
Q1 25
-4.3%
-47.7%
Q4 24
4.0%
Q3 24
2.3%
-29.5%
Q2 24
1.2%
-24.3%
Q1 24
-8.9%
-39.6%
Net Margin
OMCL
OMCL
ZEPP
ZEPP
Q4 25
Q3 25
1.8%
-2.1%
Q2 25
1.9%
-13.0%
Q1 25
-2.6%
-51.2%
Q4 24
Q3 24
3.1%
-31.2%
Q2 24
1.3%
-26.7%
Q1 24
-6.4%
-36.8%
EPS (diluted)
OMCL
OMCL
ZEPP
ZEPP
Q4 25
$-0.05
Q3 25
$0.12
$-0.01
Q2 25
$0.12
$-0.07
Q1 25
$-0.15
$-0.17
Q4 24
$0.34
Q3 24
$0.19
$-0.01
Q2 24
$0.08
$-0.01
Q1 24
$-0.34
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OMCL
OMCL
ZEPP
ZEPP
Cash + ST InvestmentsLiquidity on hand
$196.5M
$8.7M
Total DebtLower is stronger
$9.6M
Stockholders' EquityBook value
$1.2B
$31.2M
Total Assets
$2.0B
$80.9M
Debt / EquityLower = less leverage
0.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OMCL
OMCL
ZEPP
ZEPP
Q4 25
$196.5M
Q3 25
$180.1M
$8.7M
Q2 25
$399.0M
$7.8M
Q1 25
$386.8M
$10.7M
Q4 24
$369.2M
Q3 24
$570.6M
$16.4M
Q2 24
$556.8M
$17.0M
Q1 24
$512.4M
$17.9M
Total Debt
OMCL
OMCL
ZEPP
ZEPP
Q4 25
Q3 25
$9.6M
Q2 25
$9.7M
Q1 25
$9.6M
Q4 24
Q3 24
$5.7M
Q2 24
$7.3M
Q1 24
$11.2M
Stockholders' Equity
OMCL
OMCL
ZEPP
ZEPP
Q4 25
$1.2B
Q3 25
$1.2B
$31.2M
Q2 25
$1.3B
$31.1M
Q1 25
$1.3B
Q4 24
$1.2B
Q3 24
$1.2B
Q2 24
$1.2B
$44.6M
Q1 24
$1.2B
Total Assets
OMCL
OMCL
ZEPP
ZEPP
Q4 25
$2.0B
Q3 25
$1.9B
$80.9M
Q2 25
$2.1B
$75.8M
Q1 25
$2.2B
$71.6M
Q4 24
$2.1B
Q3 24
$2.3B
$81.3M
Q2 24
$2.3B
$79.7M
Q1 24
$2.3B
$80.5M
Debt / Equity
OMCL
OMCL
ZEPP
ZEPP
Q4 25
Q3 25
0.31×
Q2 25
0.31×
Q1 25
Q4 24
Q3 24
Q2 24
0.16×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OMCL
OMCL
ZEPP
ZEPP
Operating Cash FlowLast quarter
$30.4M
Free Cash FlowOCF − Capex
$22.6M
FCF MarginFCF / Revenue
7.2%
Capex IntensityCapex / Revenue
2.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$86.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OMCL
OMCL
ZEPP
ZEPP
Q4 25
$30.4M
Q3 25
$28.3M
Q2 25
$42.8M
Q1 25
$25.9M
Q4 24
$56.3M
Q3 24
$22.8M
Q2 24
$58.7M
Q1 24
$50.0M
Free Cash Flow
OMCL
OMCL
ZEPP
ZEPP
Q4 25
$22.6M
Q3 25
$18.5M
Q2 25
$31.0M
Q1 25
$14.8M
Q4 24
$47.2M
Q3 24
$13.9M
Q2 24
$49.1M
Q1 24
$41.0M
FCF Margin
OMCL
OMCL
ZEPP
ZEPP
Q4 25
7.2%
Q3 25
6.0%
Q2 25
10.7%
Q1 25
5.5%
Q4 24
15.4%
Q3 24
4.9%
Q2 24
17.8%
Q1 24
16.7%
Capex Intensity
OMCL
OMCL
ZEPP
ZEPP
Q4 25
2.5%
Q3 25
3.1%
Q2 25
4.1%
Q1 25
4.1%
Q4 24
3.0%
Q3 24
3.1%
Q2 24
3.5%
Q1 24
3.6%
Cash Conversion
OMCL
OMCL
ZEPP
ZEPP
Q4 25
Q3 25
5.18×
Q2 25
7.58×
Q1 25
Q4 24
Q3 24
2.64×
Q2 24
15.72×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OMCL
OMCL

Connected Devices Software Licenses And Other$154.2M49%
Technical Services$67.6M22%
Saa S And Expert Services$66.5M21%
Consumables$25.6M8%

ZEPP
ZEPP

Segment breakdown not available.

Related Comparisons